Drug Profile
Carbon-13 uracil breath test - Otsuka Pharmaceutical
Alternative Names: 13C-Uracil breath test; C13-URA; Uracil (2-13C)Latest Information Update: 02 May 2019
Price :
$50
*
At a glance
- Originator Otsuka Pharmaceutical
- Class Imaging agents; Radiopharmaceutical diagnostics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Chemotherapy-induced damage; Gastrointestinal motility disorders
Most Recent Events
- 02 May 2019 Chemical structure information added
- 31 Dec 2015 Discontinued - Phase-II for Gastrointestinal motility disorders (Diagnosis) in USA (PO)
- 30 Sep 2015 Phase-II clinical trials in Gastrointestinal motility disorders (Diagnosis) in USA (PO) before September 2015